Foschi, Matteo
Giannini, Giulia
Merli, Elena
Mancinelli, Luca
Zenesini, Corrado
Viti, Beatrice
Guaraldi, Pietro
Cortelli, Pietro
Lugaresi, Alessandra http://orcid.org/0000-0003-2902-5589
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
Article History
Received: 18 February 2020
Accepted: 19 July 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: In the last 3 years, Alessandra Lugaresi has served as a Biogen, Merck, Mylan, Novartis, Roche, Sanofi/Genzyme, and Teva Advisory Board Member. She received congress and travel/accommodation expense compensations or speaker honoraria from Biogen, Merck, Mylan, Novartis, Sanofi/Genzyme, Teva, and Fondazione Italiana Sclerosi Multipla (FISM). Her institutions received research grants from Novartis. Other authors report no disclosures relevant to the manuscript.
: The research was approved by the local ethics committee (Approval Code: 16151; date of approval: December 15, 2016). Every subject included gave written informed consent to participate and for the publication of data.